Search Results - "Surgo, A."

Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: Systematic review by Kobiela, J., Spychalski, P., Marvaso, G., Ciardo, D., Dell’Acqua, V., Kraja, F., Błażyńska-Spychalska, A., Łachiński, A.J., Surgo, A., Glynne-Jones, R., Jereczek-Fossa, B.A.

“…•SBRT is a novel and promising modality in treatment of oligometastatic CRC with local control up to 92% at 2 years.•Higher number of metastases seems to be…”
Get full text

Linac-based STereotactic Arrhythmia Radioablation (STAR) for ventricular tachycardia: a treatment planning study by Bonaparte, I., Gregucci, F., Surgo, A., Di Monaco, A., Vitulano, N., Ludovico, E., Carbonara, R., Ciliberti, M. P., Quadrini, F., Grimaldi, M., Fiorentino, A.

“…Object To analyze geometrical approaches, prescription modalities, and delivery efficiency for linear accelerator (Linac)-based STereotactic Arrhythmia…”
Get full text

Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences by Ost, P, Jereczek-Fossa, B.A, Van As, N, Zilli, T, Tree, A, Henderson, D, Orecchia, R, Casamassima, F, Surgo, A, Miralbell, R, De Meerleer, G

“…Abstract Aims To report the relapse pattern of stereotactic body radiotherapy (SBRT) for oligorecurrent nodal prostate cancer (PCa). Materials and methods PCa…”
Get full text

Stereotactic radiation therapy in oligometastatic colorectal cancer: outcome of 102 patients and 150 lesions by Dell’Acqua, V., Surgo, A., Kraja, F., Kobiela, J., Zerella, Maria Alessia, Spychalski, P., Gandini, S., Francia, C. M., Ciardo, D., Fodor, C., Ferrari, A. M., Piperno, G., Cattani, F., Vigorito, S., Pansini, F., Petz, W., Orecchia, R., Leonardi, M. C., Jereczek-Fossa, B. A.

“…To evaluate the local control (LC), progression free survival (PFS), out-field PFS, overall survival (OS), toxicity and failure predictors of SRT in a series…”
Get full text

Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer by Jereczek-Fossa, B. A., Maucieri, A., Marvaso, G., Gandini, S., Fodor, C., Zerini, D., Riva, G., Alessandro, O., Surgo, A., Volpe, S., Fanetti, G., Arculeo, S., Zerella, M. A., Parisi, S., Maisonneuve, P., Vavassori, A., Cattani, F., Cambria, R., Garibaldi, C., Starzyńska, A., Musi, G., De Cobelli, O., Ferro, M., Nolè, F., Ciardo, D., Orecchia, R.

“…To report toxicity and efficacy outcome of moderately hypofractionated image-guided external-beam radiotherapy in a large series of patients treated for…”
Get full text

EP-1370: Stereotactic body radiotherapy in 117 oligometastatic lymph node recurrent prostate cancer patients by Fanetti, G, Jereczek-Fossa, B.A, Fodor, C, Francia, C.M, Zerini, D, Surgo, A, Muto, M, Gerardi, M.A, Dicuonzo, S, Cambria, R, Garibaldi, C, Pansini, F, Bazani, A, De Cobelli, O, Orecchia, R

Get full text

Genital marginal failures after intensity-modulated radiation therapy (IMRT) in squamous cell anal cancer: no higher risk with IMRT when compared to 3DCRT by Dell’Acqua, V., Kobiela, J., Kraja, F., Leonardi, M. C., Surgo, A., Zerella, M. A., Arculeo, S., Fodor, C., Ricotti, R., Zampino, M. G., Ravenda, S., Spinoglio, G., Biffi, R., Bazani, A., Luraschi, R., Vigorito, S., Spychalski, P., Orecchia, R., Glynne-Jones, R., Jereczek-Fossa, B. A.

“…Intensity-modulated radiotherapy (IMRT) is considered the preferred option in squamous cell canal cancer (SCAC), delivering high doses to tumor volumes while…”
Get full text

OC-0448: Give me five: extreme hypofractionated IG-IMRT for organ confined prostate cancer by Jereczek-Fossa, B.A, Ciardo, D, Colangione, S.P, Fodor, C, Zerini, D, Cecconi, A, Surgo, A, Gerardi, M.A, Muto, M, Timon, G, Comi, S, Pansini, F, Bazani, A, Maestri, D, Garioni, M, Scroffi, V, Cattani, F, Cambria, R, De Cobelli, O, Orecchia, R

Get full text

EP-1124: Cyberknife radiotherapy for spine metastases: feasibility and acute toxicity by Ferrari, A, Cecconi, A, Jereczek-Fossa, B.A, Fodor, C, Rondi, E, Vigorito, S, Surgo, A, Cattani, F, Orecchia, R

Get full text

PO-0848: Image-guided lung stereotactic treatments with the vero system by Garibaldi, C, Ferrari, A.M, Comi, S, Surgo, A, Piperno, G, Pansini, F, Cannella, M, Rampinelli, A, Ciardo, D, Orecchia, R

Get full text

PO-0768: VERO Mitsubishi/BrainLab RT: Case profile, feasibility and acute toxicity in consecutive 686 patients/819 lesions by Muto, M, Surgo, A, Jereczek-Fossa, B.A, Fodor, C, Piperno, G, Colangione, S.P, Ferrari, A, Comi, S, Garibaldi, C, Orecchia, R

Get full text

Prognostic factors and outcomes in 28 cases of uterine leiomyosarcoma by Loizzi, V, Cormio, G, Nestola, D, Falagario, M, Surgo, A, Camporeale, A, Putignano, G, Selvaggi, L

“…It was the aim of this study to evaluate clinicopathological characteristics and prognostic factors of uterine leiomyosarcomas (LMS). Twenty-eight patients…”
Get more information

EP-1119: CyberKnife radiotherapy for brain metastases: experience of European Institute of Oncology, Milan, Italy by Cecconi, A, Jereczek-Fossa, B.A, Ferrari, A, Fodor, C, Piperno, G, Vigorito, S, Rondi, E, Surgo, A, Dispinzieri, M, Orecchia, R

Get full text

VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions by Orecchia, R, Surgo, A, Muto, M, Ferrari, A, Piperno, G, Gerardi, M A, Comi, S, Garibaldi, C, Ciardo, D, Bazani, A, Golino, F, Pansini, F, Fodor, C, Romanelli, P, Maestri, D, Scroffi, V, Mazza, S, Jereczek-Fossa, B A

“…The aim of this retrospective study is to evaluate patient profile, feasibility, and acute toxicity of RadioTherapy (RT) delivered by VERO® in the first 20…”
Get full text

PO-1446: Multiple brain metastases (BMs) radiosurgery (SRS) with single isocenter: ALDO or ILA? by Gregucci, F., Bonaparte, I., Surgo, A., Carbonara, R., Fiorentino, A.

Get full text

PO-1075 Psychologist's key role in the radiotherapy care pathway: the role of telemedicine by Caliandro, M., Gregucci, F., Surgo, A., Carbonara, R., Ciliberti, M.P., Paulicelli, E., Bonaparte, I., Fiorentino, A.

Get full text

PO-1126 Hypofractionated radiotherapy in poor prognosis patients affected by glioblastoma by Fiorentino, A., Surgo, A., Bonaparte, I., Ciliberti, M.P., Carbonara, R., Caliandro, M., Gregucci, F.

Get full text

PO-1167 Re-irradiation in glioblastoma: is it possible? Is it feasible? by Surgo, A., Gregucci, F., Laera, L., Carbonara, R., Ciliberti, M.P., Caliandro, M., Bonaparte, I., Fiorentino, A.

Get full text

PO-1144 Radiosurgery and Regorafenib in recurrent high-grade gliomas: is it feasible? by Surgo, A., Gregucci, F., Laera, L., Ciliberti, M.P., Carbonara, R., Caliandro, M., Paulicelli, E., Surico, G., Bonaparte, I., Fiorentino, A.

Get full text

PO-1476 Extreme hypofractionated SBRT for elderly prostate cancer patients: results of a phase II trial by Carbonara, R., Gregucci, F., Surgo, A., Ciliberti, M.P., Di Guglielmo, F.C., Paulicelli, E., Bonaparte, I., Fiorentino, A.

Get full text